Orient Pharma Co., Ltd. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was TWD 269.539 million compared to TWD 229.121 million a year ago. Operating loss was TWD 249.056 million compared to TWD 308.731 million a year ago. Net loss was TWD 160.101 million compared to TWD 264.829 million a year ago. Basic loss per share was TWD 1.03 compared to TWD 1.94 a year ago.